This photo provided by Myriad Genetics shows packaging for their PROLARIS sample kits for assessing prostate cancer risk. This kit made available in 2012 will be joined by another genetic test to gauge the aggressiveness of prostate cancer may help tens of thousands of men each year decide whether they need to treat their cancer right away or can safely monitor it.
This photo provided by Myriad Genetics shows packaging for their PROLARIS sample kits for assessing prostate cancer risk. This kit made available in 2012 will be joined by another genetic test to gauge the aggressiveness of prostate cancer may help tens of thousands of men each year decide whether they need to treat their cancer right away or can safely monitor it. Myriad Genetics/ASSOCIATED PRESS
This photo provided by Myriad Genetics shows packaging for their PROLARIS sample kits for assessing prostate cancer risk. This kit made available in 2012 will be joined by another genetic test to gauge the aggressiveness of prostate cancer may help tens of thousands of men each year decide whether they need to treat their cancer right away or can safely monitor it. Myriad Genetics/ASSOCIATED PRESS

Living

March 24, 2014 8:00 PM

With genetic testing, patients can see the future

Suggested for you

  Comments  

Videos

Entertainment Videos